Darunavir/ritonavir 600/100 mg once daily: it’s time for larger non-inferiority randomized trials
Autor: | Fabio Rigo, M. Lanzafame, E. Concia, Emanuela Lattuada, Stefano Nicolè, Giulia Cucchetto |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
Male 0301 basic medicine Microbiology (medical) medicine.medical_specialty Darunavir+Ritonavir Equivalence Trials as Topic Anti-HIV Agents Cross-sectional study 030106 microbiology MEDLINE HIV Infections law.invention Cohort Studies 03 medical and health sciences Non inferiority Randomized controlled trial law Darunavir/ritonavir 600/100 mg Internal medicine medicine Humans Drug Dosage Calculations Pharmacology (medical) Darunavir Pharmacology Ritonavir business.industry Middle Aged Cross-Sectional Studies Infectious Diseases HIV-1 Female Once daily business Cohort study |
Zdroj: | Journal of Antimicrobial Chemotherapy. 73:1728-1730 |
ISSN: | 1460-2091 0305-7453 |
Databáze: | OpenAIRE |
Externí odkaz: |